Prognostic Importance of the Soluble Form of IL-2 Receptor^|^alpha; (sIL-2R^|^alpha;) and Its Relationship With Surface Expression of IL-2R^|^alpha; (CD25) of Lymphoma Cells in Diffuse Large B-Cell Lymphoma Treated With CHOP-like Regimen With or Without Rituximab : A Retrospective Analysis of 338 Cases

Journal of clinical and experimental hematopathology : JCEH - Japan
doi 10.3960/jslrt.53.197
Full Text
Abstract

Available in full text

Categories
Medicine
Date
Authors
Publisher

Japanese Society for Lymphoreticular Tissue Research

Related search

The Interleukin 2 Receptor (IL-2R): The IL-2R Alpha Subunit Alters the Function of the IL-2R Beta Subunit to Enhance IL-2 Binding and Signaling by Mechanisms That Do Not Require Binding of IL-2 to IL-2R Alpha Subunit.

Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
1992English

Prognostic Significance of Survivin and Caspase-3 Immunohistochemical Expression in Patients With Diffuse Large B-Cell Lymphoma Treated With Rituximab and CHOP

Pathology and Oncology Research
MedicineForensic MedicinePathologyOncologyCancer Research
2010English

MELK Serves as a Potent Independent Biomarker to Predict Survival of Diffuse Large B-Cell Lymphoma Patients Treated With Rituximab-Chop Regimen

Hematological Oncology
MedicineCancer ResearchOncologyHematology
2017English

Tumor Necrosis as a Prognostic Factor of Diffuse Large B-Cell Lymphoma Treated With R-Chop Therapy

Hematological Oncology
MedicineCancer ResearchOncologyHematology
2017English

Response of Diffuse Large B-Cell Lymphoma Treated With R-Chop and Prognostic Factors Associated: A Single Institution Analysis in Lima, Peru

Hematological Oncology
MedicineCancer ResearchOncologyHematology
2017English

Prognostic Significance of Ki67 and Its Correlation With Mitotic Index in Dogs With Diffuse Large B-Cell Lymphoma Treated With 19-Week CHOP-based Protocol

Journal of Veterinary Diagnostic Investigation
Veterinary
2017English

PROGNOSTIC FACTORS (PFs) IN PRIMARY MEDIASTINAL LARGE B-Cell LYMPHOMA (PMLBCL) TREATED WITH RITUXIMAB-CHOP (RCHOP) ± RADIOTHERAPY (RT)

Hematological Oncology
MedicineCancer ResearchOncologyHematology
2019English

Identification of Gene Modules Associated With Survival of Diffuse Large B-Cell Lymphoma Treated With CHOP-based Chemotherapy

Pharmacogenomics Journal
Molecular MedicineGeneticsPharmacology
2020English

Diffuse Large B-Cell Lymphoma Presenting With Gastrocolic Fistula and Successfully Treated With R-Chop Chemotherapy

Tenri Medical Bulletin
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy